Identification of small molecule inhibitors against UBE2C by using docking studies
Authors:
- Kesavan SabithaKSKesavan Sabitha
- Thangarajan RajkumarTRThangarajan Rajkumar
Open Access
- 31 October 2012
- journal article
- Published by Biomedical Informatics in Bioinformation
- Vol. 8 (21) , 1047-1058
Abstract
An increased expression of UBE2C (Ubiquitin-conjugating enzyme E2C) has been associated with high tumor grade and cancer progression. It is an essential indicator of the mitotic destruction events. Our microarray study on cervical cancers showed UBE2C to be over expressed in cervical cancer. Subsequent studies from our laboratory, showed that inhibition of UBE2C can enhance radiation and chemosensitivity. Therefore it can be an appropriate target for drug development to identify potential and specific inhibitor of cancer. To identify small molecule inhibitors, a computational approach was used to model UBE2C and further docking studies were carried out. Different ligand subsets such as ChemBank, PDB, KEGG, Drug-likeness NCI, Not annotated NCI of ligand library ligands were downloaded and docked with UBE2C. Schrodinger tools were used for identifying active sites and docking studies of ligands with UBE2C. Based on glide score, the potential ligands were screened and its interaction with UBE2C was identified. We also analyzed the drug like properties such as absorption, distribution, metabolism, excretion and toxicity (ADME/T) of docked compounds. Our results suggest that 2,4-diimino-1-methyl-1,3,5-triazepan-6-one, sulfuric acid compound with 5,6-diamino-2,4-pyrimidinediol (1:1) and 7-alpha-d-ribofuranosyl-2-aminopurine-5'-phosphate may act as best inhibitors and further in vitro studies, may lead to development of novel and best inhibitor of UBE2C.Keywords
This publication has 33 references indexed in Scilit:
- Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiationInternational Journal of Radiation Biology, 2012
- Spindle Assembly Checkpoint Protein Cdc20 Transcriptionally Activates Expression of Ubiquitin Carrier Protein UbcH10Journal of Biological Chemistry, 2011
- Identification and validation of genes involved in cervical tumourigenesisBMC Cancer, 2011
- A 7 gene expression score predicts for radiation response in cancer cervixBMC Cancer, 2009
- Aneuploidy and cancerJournal of Cellular Biochemistry, 2007
- Does aneuploidy cause cancer?Current Opinion in Cell Biology, 2006
- Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal InstabilityClinical Cancer Research, 2006
- The kinetochore and cancer: what's the connection?Current Opinion in Cell Biology, 2005
- The spindle checkpoint, aneuploidy, and cancerOncogene, 2004
- UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.2003